Dr Lalchandani Labs Ltd
DRLALCHANDANILABSLTDNSE
₹0.00▲ +0.00 (+0.00%)
Whole company worth₹7 Cr
Price for ₹1 of profit₹112
1-year range₹6 – ₹19
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
The short version
A shrinking, thinly profitable business — priced richly for what it earns.
What Dr Lalchandani Labs does
Incorporated in 2011, Dr.
Worked out from Dr Lalchandani Labs's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.
01What does it do?
Dr Lalchandani Labs is a micro-sized company in healthcare service provider.
Incorporated in 2011, Dr.
- Whole company is worth
- ₹7.1 crore
- Shareholders
- 234 people
- Listed since
- 2018
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales have shrunk 16% a year for 5 years.
Profit, though, fell 51% a year over the same stretch.
Point at a bar for exact figures · amounts in ₹ crore
03Does it make money?
Out of every ₹100 it sells, it keeps ₹0.7 as profit.
Here is where the money from Dr Lalchandani Labs's sales went in FY26, the latest full year it has reported.
₹85
₹14
- ₹85Costs of running the businessstaff, rent, marketing, power and everything else
- ₹0.5Interest on its loansthe cost of borrowed money
- ₹14Wear and tearmachines, stores and buildings losing value over time
- ₹0.7Profit it keepswhat is left for the company's owners
On the money its owners have put in
It earns ₹1 a year on every ₹100 its owners have invested.
Bank FD ~₹6–7
₹1
₹-10₹0₹10₹20₹30₹40
That figure is called return on equity (ROE). Under ₹12 is a thin return for the risk of owning shares. For comparison, a bank fixed deposit pays roughly ₹6–7.
Does the profit turn into cash?
For every ₹100 of profit it reported, ₹-57 actually came in as cash.
Profit it reported₹1.1 Cr
Cash its business brought in−₹0.6 Cr
Over the last 3 years: ₹1.1 crore of profit but only −₹0.6 crore of cash. A wide gap like this is worth understanding before trusting the profit figure.
04Is the price high or low?
You pay ₹112 for every ₹1 of profit it makes in a year.
This is the P/E ratio: share price divided by a year's profit per share. A P/E of 112 means buyers are paying for about 112 years of today's profit up front.
The share price over the past year
05Who owns it?
Its founders and parent group own 33 of every 100 shares — a large stake, though not a majority.
If the company were split into 100 equal shares, this is who would hold them. Last quarter, founders & parent group raised their stake by 1.8 percentage points. 234 people and institutions hold its shares.
As filed for the quarter ending 31 Mar 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
The figures raise more questions than they answer.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
Nothing stands out in its favour in the figures we have.
Worth watching
- Sales have been shrinking — 16% a year.
- The share price is 112 times a year's profit, so it leans heavily on growth continuing.
07What happened lately?
Its latest quarter.
Jan–Mar 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹2.1 Cr
Loss
₹0.1 Cr
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Dr Lalchandani Labs?
This page describes Dr Lalchandani Labs using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Dr Lalchandani Labs Ltd (DRLALCHANDANILABSLTD): company summary
Dr Lalchandani Labs Ltd (DRLALCHANDANILABSLTD) is a micro-cap Healthcare Services company valued at ₹7 crore operating in Healthcare Service Provider on the NSE and BSE.
Dr Lalchandani Labs Ltd (DRLALCHANDANILABSLTD) is a micro-cap Healthcare Services company valued at ₹7 crore operating in Healthcare Service Provider on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -6.0% a year over three years. Return on equity is 0.5%.
- Valuation multiples
- The stock trades at 112.0 times earnings, 0.48 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Healthcare Services stocks · Healthcare Service Provider
Explore Dr Lalchandani Labs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Dr Lalchandani Labs Ltd peers in Healthcare Services
Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.
Related tools & concepts
Value Dr Lalchandani Labs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing